InflaRx NV (FRA:IF0) FFO


FRA:IF0 InflaRx NV FRA:IF0
28 GF Score
Price €1.54
! 5 Warning Signs
View Full Analysis

What is InflaRx NV FFO?

FFO (Funds from operations) only applies to REITs.

FRA:IF0
28GF Score
InflaRx NV FRA:IF0
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

InflaRx NV Business Description

Other Exchanges IFRX:USA
Address Winzerlaer Strasse 2, Jena, DEU, 07745
InflaRx NV is a biopharmaceutical company applying proprietary technologies to discover, develop and commercialize potent and specific inhibitors of the complement activation factor known as C5a and its receptor C5aR. With its therapeutic product candidates, vilobelimab and izicopan, the company targets C5a and its receptor C5aR to selectively inhibit the powerful inflammatory response observed in a wide variety of autoimmune and other inflammatory diseases elicited through C5a/C5aR activation. Its product candidate, GOHIBIC (vilobelimab), is a novel intravenously delivered anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.
28GF Score

Get the complete analysis for FRA:IF0

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.54
Price